Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Feagan

Showing results (371-380 of 464) with videos related to

Pageof 47
Sort By:
Gut|August 5, 2018
Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trialVipul Jairath, Laurent Peyrin-Biroulet, Guangyong Zou, et al.
Gastroenterology|September 2, 2023
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction StudyLaurent Peyrin-Biroulet, Jessica R Allegretti, David T Rubin, et al.
Journal of Crohn'S & Colitis|September 30, 2016
Long-term Efficacy of Vedolizumab for Crohn's DiseaseSeverine Vermeire, Edward V Loftus, Jean-Frédéric Colombel, et al.
Gastroenterology|April 10, 2017
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a StudyBruce E Sands, Jingjing Chen, Brian G Feagan, et al.
Inflammatory Bowel Diseases|January 24, 2018
Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by Magnetic Resonance EnterographyVipul Jairath, Ingrid Ordas, Guangyong Zou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 30, 2018
Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic ReviewChristopher Ma, Isra M Hussein, Yousef J Al-Abbar, et al.
Abdominal Radiology (New York)|December 18, 2024
Discordance between MR enterography and endoscopic detection of Crohn's disease ileal strictures: evidence to inform recommendationsMariana Yalon, Payam Mohammadinejad, Akitoshi Inoue, et al.
The American Journal of Gastroenterology|October 16, 2013
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imagingWilliam A Faubion, Joel G Fletcher, Sharon O'Byrne, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2023
Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn's Disease ActivityVirginia Solitano, David F Schaeffer, Malcolm Hogan, et al.
Journal of Crohn'S & Colitis|April 3, 2018
Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel DiseasePim J Koelink, Manon E Wildenberg, Larry W Stitt, et al.
Pageof 47

Showing results (371-380 of 464) with videos related to

Sort By:
Pageof 47
Gut|August 5, 2018
Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trialVipul Jairath, Laurent Peyrin-Biroulet, Guangyong Zou, et al.
Gastroenterology|September 2, 2023
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction StudyLaurent Peyrin-Biroulet, Jessica R Allegretti, David T Rubin, et al.
Journal of Crohn'S & Colitis|September 30, 2016
Long-term Efficacy of Vedolizumab for Crohn's DiseaseSeverine Vermeire, Edward V Loftus, Jean-Frédéric Colombel, et al.
Gastroenterology|April 10, 2017
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a StudyBruce E Sands, Jingjing Chen, Brian G Feagan, et al.
Inflammatory Bowel Diseases|January 24, 2018
Reliability of Measuring Ileo-Colonic Disease Activity in Crohn's Disease by Magnetic Resonance EnterographyVipul Jairath, Ingrid Ordas, Guangyong Zou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 30, 2018
Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic ReviewChristopher Ma, Isra M Hussein, Yousef J Al-Abbar, et al.
Abdominal Radiology (New York)|December 18, 2024
Discordance between MR enterography and endoscopic detection of Crohn's disease ileal strictures: evidence to inform recommendationsMariana Yalon, Payam Mohammadinejad, Akitoshi Inoue, et al.
The American Journal of Gastroenterology|October 16, 2013
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imagingWilliam A Faubion, Joel G Fletcher, Sharon O'Byrne, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2023
Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn's Disease ActivityVirginia Solitano, David F Schaeffer, Malcolm Hogan, et al.
Journal of Crohn'S & Colitis|April 3, 2018
Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel DiseasePim J Koelink, Manon E Wildenberg, Larry W Stitt, et al.
Pageof 47